Diadema Partners »

Avidity Biosciences Ord shares owned by Diadema Partners

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $10M 230k 43.57

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
Rtw Investments
Wellington Management Company
BlackRock
RA Capital Management
venBio Select Advisor
State Street Corporation
Geode Capital Management
Polar Capital Holdings
Bellevue Group
Casdin Capital
Goldman Sachs Group
OrbiMed Advisors

View all funds holding Avidity Biosciences Ord